Overactive Bladder - Results from #1520

Potential of stem cell treatment in detrusor dysfunction - Abstract January 8, 2015

Adherence to fesoterodine in women with overactive bladder in routine clinical practice - Abstract January 6, 2015

Shanee Edwards and Diane K. Newman work together to fight overactive bladder January 6, 2015

Economic evaluation of pharmacological treatments for overactive bladder from the perspective of the UK National Health Service - Abstract January 6, 2015

Randomized controlled trial of cyclic and continuous therapy with trospium and solifenacin combination for severe overactive bladder in elderly patients with regard to patient compliance - Abstract January 3, 2015

Relationship between urodynamic findings and sexual function in multiple sclerosis patients with lower urinary tract dysfunction - Abstract December 19, 2014

Botulinum toxin A injection for the treatment of neurogenic detrusor overactivity secondary to spinal cord injury: Multi-institutional experience in Japan - Abstract December 18, 2014

Efficacy and tolerability of anticholinergics in Korean children with overactive bladder: A multicenter retrospective study - Abstract December 17, 2014

Prediction of overactive bladder treatment outcome by using long-term urodynamics - Abstract December 13, 2014

A comparative study on the efficacy of solifenacin succinate in patients with urinary frequency with or without urgency - Abstract December 12, 2014

Voiding dysfunction in older women with overactive bladder symptoms: A comparison of urodynamic parameters between women with normal and elevated post-void residual urine - Abstract December 11, 2014

Comparisons of therapeutic efficacy and safety of solifenacin versus tolterodine in patients with overactive bladder: A meta-analysis of outcomes - Abstract December 9, 2014

Acupuncture for overactive bladder in female adult: A randomized controlled trial - Abstract December 9, 2014

Vaginal estrogen use in postmenopausal women with pelvic floor disorders: Systematic review and practice guidelines - Abstract December 5, 2014

Use of botulinum toxin type A in non-neurogenic overactive bladder: Recommendations of the Working Group Urological Functional Diagnostics and Urology in Women - Abstract December 1, 2014

The efficacy and tolerability of tarafenacin, a new muscarinic acetylcholine receptor M3 antagonist in patients with overactive bladder; randomised, double-blind, placebo-controlled phase 2 study - Abstract November 28, 2014

Innovative pharmacotherapies for women with overactive bladder: Where are we now and what is in the pipeline? - Abstract November 27, 2014

Contribution of behavioral and cognitive therapy to managing overactive bladder syndrome in women in the absence of contributive urodynamic diagnosis - Abstract November 25, 2014

Considering the prominent complaint as a guide in medical therapy for overactive bladder syndrome in women over 45 years - Abstract November 25, 2014

Efficacy and safety of Baweidihuang-wan in women with overactive bladder: A randomized, double blind, placebo controlled trial - Abstract November 21, 2014

Page 77 of 122